CHMP2B and frontotemporal dementia: Altogether, our results show that we successfully introduced an FTD causative mutation in the intron 5 of the CHMP2B gene of a hESC line in heterozygosity, as in patients, and without introducing any unwanted alteration in the genome or in essential properties of the pluripotent stem cells.